Last viewed: PFE


Prices are updated after-hours



nyse:PFE Pfizer, Inc.

PFE | $54.05 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-9.2% 1m) (47.9% 1y) (0.0% 2d) (1.0% 3d) (-0.6% 7d) (16.96% volume)
http://www.pfizer.com
Sec Filling | Patents | 88300 employees

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Drugs
Flector (Diclofenac Epolamine)
FLECTOR (Diclofenac Epolamine)

add to today's watch list email alert is off




vaccine   immunology   brands  

Press-releases


CStone announces the GEMSTONE-302 study of sugemalimab met the endpoint of overall survival in the first-line treatment of metastatic non-small cell lung cancer patients
Published: 2022-01-19 (Crawled : 01:00) - prnewswire.com
PFE | $54.05 | twitter stocktwits trandingview |
Health Technology
| | O: -1.32% H: 1.57% C: -0.21%

stone-302 treatment ema ces era cel lung cancer cancer
Investor Alert: The M&A Class Action Firm Continues Investigating the Merger - VG, TACO, ARNA, UMPQ, LEVL, NES
Published: 2022-01-15 (Crawled : 08:20) - prnewswire.com
NES | $1.92 | twitter stocktwits trandingview |
Utilities

BOX | $25.21 | twitter stocktwits trandingview |
Technology Services

LEVL | $40.42 | twitter stocktwits trandingview |
Finance

COLB | $34.93 | twitter stocktwits trandingview |
Finance

ARNA | $91.01 | twitter stocktwits trandingview |
Health Technology

WTTR | $6.62 | twitter stocktwits trandingview |
Industrial Services

PFE | $54.05 | twitter stocktwits trandingview |
Health Technology

ERIC | News 1 d | $11.465 | twitter stocktwits trandingview |
Electronic Technology

VG | $20.79 | twitter stocktwits trandingview |
Communications

TACO | News | $12.48 | twitter stocktwits trandingview |
Consumer Services

merge
Breast Cancer Treatment Advancements Emerge After New Study Finds Global Deaths Increased in 2019
Published: 2022-01-14 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $121.21 | twitter stocktwits trandingview |
Health Technology
| | O: -0.21% H: 0.98% C: 0.98%
INCY | News | $74.76 | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: 0.0%
ONCY | $1.97 | twitter stocktwits trandingview |
Health Technology
| | O: 0.65% H: 0.0% C: 0.0%
AZN | News | $60.17 | twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.0% C: 0.0%
PFE | $54.05 | twitter stocktwits trandingview |
Health Technology
| | O: -1.01% H: 0.0% C: 0.0%

treatment cancer breast cancer merge
U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis
Published: 2022-01-14 (Crawled : 21:00) - biospace.com/
PFE | $54.05 | twitter stocktwits trandingview |
Health Technology
| | O: -1.01% H: 0.0% C: 0.0%

cibinqo fda atopic dermatitis dermatitis era
Positive Top-Line Results of Pfizer’s Phase 3 Study Exploring Coadministration of PREVNAR 20™ With Pfizer-BioNTech COVID-19 Vaccine in Older Adults Released
Published: 2022-01-12 (Crawled : 12:30) - biospace.com/
FNCTF | News | $11.58 | twitter stocktwits trandingview |
Communications
| | O: 0.0% H: 0.0% C: 0.0%
PFE | $54.05 | twitter stocktwits trandingview |
Health Technology
| | O: -0.77% H: 1.46% C: 0.55%


Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Diseases
Published: 2022-01-10 (Crawled : 12:00) - biospace.com/
PFE | $54.05 | twitter stocktwits trandingview |
Health Technology
| | O: 0.63% H: 0.0% C: 0.0%
BEAM | $62.84 | twitter stocktwits trandingview |
Health Technology
| | O: 3.65% H: 0.77% C: -2.89%


Global Depression Drugs Market to Surpass US$ 15,379.0 Million by 2028, Says Coherent Market Insights
Published: 2022-01-07 (Crawled : 19:00) - prnewswire.com
PFE | $54.05 | twitter stocktwits trandingview |
Health Technology

AZNCF | News | $121.21 | twitter stocktwits trandingview |
Health Technology

SNYNF | News 3 d | $105.0 | twitter stocktwits trandingview |
Health Technology

TAK | $14.4 | twitter stocktwits trandingview |
Health Technology

SNY | News 3 d | $52.31 | twitter stocktwits trandingview |
Health Technology

LLY | News | $246.46 | twitter stocktwits trandingview |
Health Technology

GLAXF | News | $22.8 | twitter stocktwits trandingview |
Health Technology

GSK | News | $45.14 | twitter stocktwits trandingview |
Health Technology

AZN | News | $60.17 | twitter stocktwits trandingview |
Health Technology

JNJ | News | $167.27 | twitter stocktwits trandingview |
Health Technology

drug depression
Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
Published: 2022-01-05 (Crawled : 12:30) - globenewswire.com
SNYNF | News 3 d | $105.0 | twitter stocktwits trandingview |
Health Technology
| | O: 3.68% H: 0.0% C: 0.0%
BNTX | $156.53 | twitter stocktwits trandingview |
Health Technology
| | O: -0.85% H: 0.0% C: 0.0%
SNY | News 3 d | $52.31 | twitter stocktwits trandingview |
Health Technology
| | O: 0.91% H: 0.0% C: 0.0%
PFE | $54.05 | twitter stocktwits trandingview |
Health Technology
| | O: -0.73% H: 0.0% C: 0.0%

collaboration vaccine
Arena Pharmaceuticals INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arena Pharmaceuticals, Inc. - ARNA
Published: 2022-01-05 (Crawled : 05:00) - prnewswire.com
ARNA | $91.01 | twitter stocktwits trandingview |
Health Technology
| | O: 0.04% H: 0.55% C: -0.3%
PFE | $54.05 | twitter stocktwits trandingview |
Health Technology
| | O: -0.73% H: 0.0% C: 0.0%

als ces era
Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States
Published: 2022-01-05 (Crawled : 17:00) - biospace.com/
PFE | $54.05 | twitter stocktwits trandingview |
Health Technology
| | O: -0.73% H: 0.0% C: 0.0%
BHVN | $116.0 | twitter stocktwits trandingview |
Health Technology
| | O: 0.43% H: 0.9% C: -4.35%
BMY | $64.58 | twitter stocktwits trandingview |
Health Technology
| | O: 1.38% H: 0.0% C: 0.0%

commercialization collaboration
See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying